The following is a list of the top 100 prescribed medicines by U.S. National Sales in Q1 2013. Figures include sales through both retail and hospital channels, listed by drug name and sales value in U.S. dollars.
| Rank |
Drug |
Sales ($000) |
|
|
| 1 |
Abilify
Otsuka Pharmaceutical Co. |
1,526,228 |
3.24% |
Stats |
| 2 |
Nexium
AstraZeneca Pharmaceuticals |
1,458,964 |
1.21% |
Stats |
3 ( 1) |
Cymbalta
Eli Lilly and Company |
1,296,843 |
5.65% |
Stats |
4 ( 1) |
Crestor
AstraZeneca Pharmaceuticals |
1,295,760 |
1.59% |
Stats |
| 5 (1) |
Advair Diskus
GlaxoSmithKline |
1,277,171 |
6.00% |
Stats |
| 6 (1) |
Humira
Abbott Laboratories |
1,217,353 |
0.91% |
Stats |
| 7 |
Enbrel
Amgen Inc. |
1,075,249 |
-1.22% |
Stats |
| 8 |
Remicade
Centocor Ortho Biotech, Inc |
969,058 |
3.58% |
Stats |
| 9 |
Copaxone
Teva Pharmaceuticals |
926,021 |
1.98% |
Stats |
| 10 |
Neulasta
Amgen Inc. |
859,062 |
6.94% |
Stats |
| 11 |
Rituxan
Genentech, Inc |
794,464 |
1.98% |
Stats |
| 12 |
Spiriva
Boehringer Ingelheim Pharmaceuticals, Inc |
726,057 |
3.39% |
Stats |
| 13 |
Atripla
Gilead Sciences, Inc. |
723,408 |
4.03% |
Stats |
| 14 (1) |
Januvia
Merck & Co., Inc. |
701,126 |
6.40% |
Stats |
| 15 (1) |
OxyContin
|
652,536 |
-2.38% |
Stats |
| 16 |
Avastin
Genentech, Inc |
640,823 |
1.04% |
Stats |
| 17 (1) |
Lantus Solostar
Sanofi-Aventis |
637,157 |
6.60% |
Stats |
| 18 (1) |
Lantus
Sanofi-Aventis |
592,333 |
-1.17% |
Stats |
| 19 (2) |
Lyrica
Pfizer Inc |
553,016 |
8.10% |
Stats |
| 20 (3) |
Diovan
Novartis Corporation |
538,141 |
13.39% |
Stats |
| 21 (2) |
Truvada
Gilead Sciences, Inc. |
536,928 |
-5.11% |
Stats |
| 22 |
Celebrex
Pfizer Inc |
518,329 |
2.47% |
Stats |
| 23 (3) |
Epogen
Amgen Inc. |
503,493 |
-2.08% |
Stats |
| 24 |
Herceptin
Genentech, Inc |
471,387 |
1.43% |
Stats |
| 25 |
Namenda
Forest Pharmaceuticals, Inc |
448,659 |
-1.32% |
Stats |
| 26 |
Gleevec
Novartis Corporation |
438,105 |
0.41% |
Stats |
| 27 (1) |
Vyvanse
Shire US Inc |
430,909 |
5.48% |
Stats |
| 28 (1) |
Suboxone
Reckitt Benckiser Pharmaceuticals Inc. |
415,929 |
-0.32% |
Stats |
| 29 (1) |
Lucentis
Genentech, Inc |
415,406 |
4.92% |
Stats |
| 30 (16) |
Synagis
MedImmune, Inc |
412,703 |
46.47% |
Stats |
| 31 (1) |
Zetia
Merck & Co., Inc. |
395,066 |
5.27% |
Stats |
| 32 (32) |
Tamiflu
Roche Pharmaceuticals |
392,115 |
65.38% |
Stats |
| 33 (4) |
methylphenidate
Generic |
383,354 |
-4.09% |
Stats |
| 34 (3) |
Symbicort
AstraZeneca Pharmaceuticals |
376,822 |
10.70% |
Stats |
| 35 (1) |
ONE TOUCH ULTRA
|
368,604 |
5.36% |
Stats |
| 36 (5) |
enoxaparin
Generic |
365,091 |
-7.37% |
Stats |
| 37 (1) |
AndroGel
Abbott Laboratories |
348,205 |
0.49% |
Stats |
| 38 (3) |
Lidoderm
Endo Pharmaceuticals |
345,620 |
-0.86% |
Stats |
| 39 (6) |
Avonex
Biogen Idec |
338,236 |
-9.05% |
Stats |
| 40 |
Levemir
Novo Nordisk Inc. |
335,926 |
8.81% |
Stats |
| 41 (3) |
Rebif
|
332,452 |
6.61% |
Stats |
| 42 (3) |
Novolog
Novo Nordisk Inc. |
322,779 |
3.74% |
Stats |
| 43 (1) |
NovoLog FlexPen
Novo Nordisk Inc. |
316,981 |
7.97% |
Stats |
| 44 |
Seroquel XR
AstraZeneca Pharmaceuticals |
304,400 |
6.81% |
Stats |
| 45 (2) |
Viagra
Pfizer Inc |
288,880 |
-0.69% |
Stats |
| 46 (9) |
Nasonex
Merck & Co., Inc. |
283,875 |
8.87% |
Stats |
| 47 (1) |
Niaspan
Abbott Laboratories |
281,011 |
4.80% |
Stats |
| 48 (8) |
Humalog
Eli Lilly and Company |
279,018 |
8.17% |
Stats |
| 49 (8) |
Alimta
Eli Lilly and Company |
273,747 |
-8.17% |
Stats |
| 50 (2) |
budesonide
Generic |
271,635 |
2.21% |
Stats |
| 51 (27) |
fenofibrate
Generic |
268,473 |
29.97% |
Stats |
| 52 (1) |
Lovaza
GlaxoSmithKline |
267,926 |
0.70% |
Stats |
| 53 (6) |
Flovent HFA
GlaxoSmithKline |
266,820 |
-0.67% |
Stats |
| 54 (1) |
Combivent
Boehringer Ingelheim Pharmaceuticals, Inc |
266,777 |
0.65% |
Stats |
| 55 (6) |
amphetamine/dextroamphetamine
Generic |
265,628 |
-0.69% |
Stats |
| 56 (11) |
ProAir HFA
Teva Pharmaceuticals |
262,338 |
-7.84% |
Stats |
| 57 (6) |
Cialis
Eli Lilly and Company |
253,451 |
6.81% |
Stats |
| 58 (1) |
acetaminophen/hydrocodone
Generic |
251,964 |
1.58% |
Stats |
| 59 (1) |
Isentress
Merck & Co., Inc. |
243,636 |
2.00% |
Stats |
| 60 (8) |
Victoza
Novo Nordisk Inc. |
242,143 |
6.43% |
Stats |
| 61 (3) |
Procrit
Janssen Pharmaceuticals, Inc |
241,175 |
-2.24% |
Stats |
| 62 (7) |
Janumet
Merck & Co., Inc. |
240,005 |
7.64% |
Stats |
| 63 (4) |
Neupogen
Amgen Inc. |
239,937 |
3.86% |
Stats |
| 64 (2) |
Reyataz
Bristol-Myers Squibb Company |
238,094 |
0.18% |
Stats |
| 65 |
Restasis
Allergan, Inc |
237,475 |
1.89% |
Stats |
| 66 (7) |
metoprolol
Generic |
236,279 |
-1.41% |
Stats |
| 67 (1) |
Gilenya
Novartis Corporation |
235,496 |
1.18% |
Stats |
| 68 (18) |
Incivek
Vertex Pharmaceuticals |
234,084 |
-12.08% |
Stats |
| 69 (3) |
Prezista
Janssen Pharmaceuticals, Inc |
226,038 |
4.35% |
Stats |
| 70 (7) |
VESIcare
Astellas Pharma US |
220,271 |
5.33% |
Stats |
| 71 |
Vytorin
Merck & Co., Inc. |
220,100 |
-0.81% |
Stats |
72 ( ) |
hydrochlorothiazide/valsartan
Generic |
219,951 |
 |
Stats |
| 73 (19) |
modafinil
Generic |
218,612 |
-17.44% |
Stats |
| 74 |
Orencia
Bristol-Myers Squibb Company |
216,942 |
2.68% |
Stats |
| 75 (4) |
Pradaxa
Boehringer Ingelheim Pharmaceuticals, Inc |
215,003 |
4.76% |
Stats |
| 76 (7) |
Renvela
Genzyme Corporation |
210,975 |
4.77% |
Stats |
| 77 (2) |
Dexilant
Takeda Pharmaceuticals North America, Inc |
210,005 |
-0.08% |
Stats |
| 78 (5) |
Aciphex
Eisai Corporation |
209,443 |
-1.84% |
Stats |
| 79 (7) |
Benicar
Daiichi Sankyo |
204,717 |
5.92% |
Stats |
| 80 (4) |
Aranesp
Amgen Inc. |
203,664 |
-3.03% |
Stats |
| 81 (12) |
Stelara
|
201,950 |
10.71% |
Stats |
| 82 () |
Humalog KwikPen
|
201,646 |
|
Stats |
| 83 (5) |
Synthroid
Abbott Laboratories |
200,695 |
5.21% |
Stats |
| 84 (5) |
Evista
Eli Lilly and Company |
197,559 |
4.03% |
Stats |
| 85 (5) |
Ventolin HFA
GlaxoSmithKline |
197,453 |
6.00% |
Stats |
| 86 (5) |
Adderall XR
Shire US Inc |
196,427 |
-3.21% |
Stats |
| 87 (5) |
Betaseron
Bayer Healthcare Pharmaceuticals |
195,574 |
-3.20% |
Stats |
| 88 (4) |
atorvastatin
Generic |
193,260 |
-1.47% |
Stats |
| 89 () |
doxycycline
Generic |
193,240 |
|
Stats |
| 90 (3) |
Lunesta
Sunovion Pharmaceuticals Inc. |
189,289 |
-1.43% |
Stats |
| 91 (6) |
fentanyl
Generic |
189,255 |
-2.58% |
Stats |
| 92 (5) |
Zyvox
Pfizer Inc |
188,084 |
11.15% |
Stats |
| 93 (2) |
Xolair
|
182,221 |
-0.33% |
Stats |
| 94 (2) |
Xgeva
Amgen Inc. |
182,194 |
4.84% |
Stats |
| 95 (15) |
Prevnar 13
Wyeth |
180,661 |
-11.69% |
Stats |
| 96 (4) |
Sensipar
Amgen Inc. |
180,218 |
-1.31% |
Stats |
| 97 (2) |
Xeloda
Roche Pharmaceuticals |
174,526 |
-2.21% |
Stats |
| 98 () |
omeprazole
Generic |
172,664 |
|
Stats |
| 99 (1) |
Focalin XR
Novartis Corporation |
171,147 |
1.74% |
Stats |
| 100 () |
Benicar HCT
Daiichi Sankyo |
170,433 |
|
Stats |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
1)
1)
)
